Oncotarget

Vol 11, No 3

January 21, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 3 of Oncotarget features Figure 3, "Hierarchical clustering of tonsil squamous cell carcinoma cohorts based on viral signature detection pattern with associated pathological features (perineural invasion (PNI), lymphovascular invasion (LVI), and tumor stage (T stage))," by Carey, et al.

Table of Contents

Editorial

Cytokine storm during chemotherapy: a new companion diagnostic emerges?

Cytokine storm during chemotherapy: a new companion diagnostic emerges?

https://doi.org/10.18632/oncotarget.27442

Panagiota S. Filippou,  and George S. Karagiannis
213-215
PDF  |  How to cite  |  Order a Reprint

Research Papers

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib

A pan-cancer transcriptome analysis identifies replication fork and innate immunity genes as modifiers of response to the CHK1 inhibitor prexasertib

https://doi.org/10.18632/oncotarget.27400

Wayne D. Blosser, Jack A. Dempsey, Ann M. McNulty, Xi Rao, Philip J. Ebert, Caitlin D. Lowery, Philip W. Iversen, Yue Wang Webster, Gregory P. Donoho, Xueqian Gong, Farhana F. Merzoug, Sean Buchanan, Karsten Boehnke, Chunping Yu, Xin Tian You, Richard P. Beckmann, Wenjuan Wu, Samuel C. McNeely, Aimee Bence Lin,  and Ricardo Martinez
216-236
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes

Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes

https://doi.org/10.18632/oncotarget.27428

Franziska Büscheck, Christoph Fraune, Ronald Simon, Martina Kluth, Claudia Hube-Magg, Christina Möller-Koop, Imren Sarper, Kathrin Ketterer, Tjark Henke, Christian Eichelberg, Roland Dahlem, Waldemar Wilczak, Guido Sauter, Margit Fisch, Till Eichenauer,  and Michael Rink
237-249
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC

TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC

https://doi.org/10.18632/oncotarget.27430

Julia Roeper, Markus Falk, Athena Chalaris-Rißmann, Anne C. Lueers, Hayat Ramdani, Katrin Wedeken, Ursula Stropiep, Linda Diehl, Markus Tiemann, Lukas C. Heukamp, Fabian Otto-Sobotka,  and Frank Griesinger
250-264
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR

Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR

https://doi.org/10.18632/oncotarget.27435

Hengyu Lu, Chen Liu, Hung Huynh, Thi Bich Uyen Le, Matthew J. LaMarche, Morvarid Mohseni, Jeffrey A. Engelman, Peter S. Hammerman, Giordano Caponigro,  and Huai-Xiang Hao
265-281
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

The virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis

The virome of HPV-positive tonsil squamous cell carcinoma and neck metastasis

https://doi.org/10.18632/oncotarget.27436

Ryan M. Carey, Karthik Rajasekaran, Tyler Seckar, Xiang Lin, Zhi Wei, Charles C.L. Tong, Viran J. Ranasinghe, Jason G. Newman, Bert W. O'Malley Jr., Gregory S. Weinstein, Michael D. Feldman,  and Erle S. Robertson
282-293
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Case Reports

Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy

Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy

https://doi.org/10.18632/oncotarget.27323

Dmitry M. Ponomarenko, Vladimir L. Gabai, Albert A. Sufianov, Sergey I. Kolesnikov,  and Alexander M. Shneider
294-299
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells

Correction: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells

https://doi.org/10.18632/oncotarget.27373

Hao Yang, Hui Hui, Qian Wang, Hui Li, Kai Zhao, Yuxin Zhou, Yu Zhu, Xiaotang Wang, Qidong You, Qinglong Guo,  and Na Lu
300-301
Correction  |  PDF  |  How to cite

Correction: Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation

Correction: Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation

https://doi.org/10.18632/oncotarget.27441

Jie Zhang, Pengxing He, Yong Xi, Meiyu Geng, Yi Chen,  and Jian Ding
302-303
Correction  |  PDF  |  How to cite

Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation

Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation

https://doi.org/10.18632/oncotarget.27450

Ying Yan, Ashley L. Hein, Asserewou Etekpo, Katrina M. Burchett, Chi Lin, Charles A. Enke, Surinder K. Batra, Kenneth H. Cowan,  and Michel M. Ouellette
304-304
Correction  |  PDF  |  How to cite

Errata

Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors

Erratum: PTEN deletion drives acute myeloid leukemia resistance to MEK inhibitors

https://doi.org/10.18632/oncotarget.27402

Amanda M. Smith, Christine R.C. Zhang, Alexandre S. Cristino, John P. Grady, J. Lynn Fink,  and Andrew S. Moore
305-305
Erratum  |  PDF  |  How to cite


Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC